Zynexの収益Y / Y
Zynexの収益Y / Yは何ですか。
Zynex, Inc.の収益Y / Yは29.59%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
HKSEのセクタHealth Careにおける収益Y / Yの企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似の収益y / y
- Azimut SpAの収益Y / Yは29.49%です。
- Energa SAの収益Y / Yは29.49%です。
- Euronav NVの収益Y / Yは29.51%です。
- Siltronic AGの収益Y / Yは29.54%です。
- Havells Indiaの収益Y / Yは29.54%です。
- Evonik Industries AGの収益Y / Yは29.55%です。
- Zynexの収益Y / Yは29.59%です。
- HBL Power Systemsの収益Y / Yは29.59%です。
- Sutlej Textiles and Industriesの収益Y / Yは29.62%です。
- Bharat Rasayanの収益Y / Yは29.62%です。
- Sprout Socialの収益Y / Yは29.64%です。
- ONE Hospitality Incの収益Y / Yは29.65%です。
- Indo Tech Transformersの収益Y / Yは29.65%です。